NHS: Drugs

Department of Health and Social Care written question – answered at on 21 January 2019.

Alert me about debates like this

Photo of Lord Warner Lord Warner Crossbench

To ask Her Majesty's Government whether the “Serious Shortage Protocol”, as set out in the document Further guidance note on the regulation of medicines, medical devices and clinical trials if there’s no Brexit deal, published on 4 January, will be applied to patients involved in clinical trials; and what assessment they have made of the risk of jeopardising the conduct of clinical trials and the data collected by the application of the protocol to such trials.

Photo of Baroness Manzoor Baroness Manzoor Baroness in Waiting (HM Household) (Whip)

The provisions exempt retail pharmacies from dispensing against a prescription when a serious shortage protocol is in place. We do not envisage it would apply to medicines not supplied on prescription, including those supplied as part of a clinical trial. Therefore, no such assessment has been made.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.